Skip to main content

PharmaSmart kiosks recommended to practitioners by hypertension experts

10/9/2014


ROCHESTER, N.Y.  — National leaders in hypertension have acknowledged PharmaSmart as the only blood pressure kiosk solution that can be “recommended by physicians” for patient monitoring, the company announced Thursday. The scientific peer-reviewed statement, published this month in the Journal of the American Society of Hypertension, is an evidence-based summary of the issues surrounding public-use blood pressure kiosk accuracy. 


 


"There are two major issues concerning many of the currently available kiosks," noted lead researcher Bruce Alpert, associated with the division of Pediatric Cardiology, University of Tennessee Health Science Center. "First, many appear to lack proper validation testing required to ensure accuracy. Second, the BP cuff incorporated into most devices is too small for about 50% of the U.S. adult populations, and an even higher percentage of hypertensive U.S. adults. Concerned physicians and scientists are working with the FDA to correct the issues," he wrote. "Fortunately, there is one currently available kiosk that has successfully addressed both points and can be recommended by physicians for their patients and for purchase to be placed in public sites."


 


“Neighborhood pharmacy and pharamcists' are playing an increasingly important role in the delivery of primary care services, and specifically in the prevention and management of certain chronic diseases," said Warren Jeffery, Rexall COO. "Rexall has deployed PharmaSmart’s Blood Pressure management program into the majority of our stores, which has enabled access for our pharmacists to patient blood pressure results and to better manage patient care.”


 


“PharmaSmart and Bartell Drugs have teamed up to drive collaborative care projects with prominent physician networks throughout Greater Seattle," said Billy Chow, director pharmacy services and clinical programs for Bartell Drugs. "These projects would not be possible without PharmaSmart’s strong clinical evidence and industry leading health IT platform.”

X
This ad will auto-close in 10 seconds